SCOPUS 정보 검색 플랫폼

Volumn 97, Issue 1, 2001, Pages 15-21

Long term improvement in the treatment of canine leishmaniosis using an antimony liposomal formulation

(10) Valladares, Josep Enric a Riera, Cristina b González Ensenyat, Pedro c Díez Cascón, Angel c Ramos, Georgina a Solano Gallego, Laia a Gállego, Montserrat b Portús, Montserrat b Arboix, Margarita a Alberola, Jordi a

a UNIVERSITAT AUTÒNOMA DE BARCELONA (Spain)

b UNIVERSITY OF BARCELONA (Spain)

c Transtechnics (Spain)

Author keywords

Antimony; Dog; Leishmania infantum; Liposomes; Meglumine antimoniate

Indexed keywords

ANTIMONY; IMMUNOGLOBULIN; LIPOSOME; MEGLUMINE ANTIMONATE; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOG; DOG DISEASE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; FOLLOW UP; LEISHMANIA INFANTUM; LEISHMANIASIS; LONG TERM CARE; MALE; NONHUMAN; PARASITOSIS; REACTION TIME; STEADY STATE;

ANIMALS; ANTIMONY; DELAYED-ACTION PREPARATIONS; DOG DISEASES; DOGS; LEISHMANIASIS; LIPOSOMES; MALE;

CANIS FAMILIARIS; LEISHMANIA INFANTUM;

EID: 0035832373 PISSN: 03044017 EISSN: None Source Type: Journal
DOI: 10.1016/S0304-4017(01)00389-2 Document Type: Article

Times cited : (42)

References (18)

1
- 0031729149
- Liposomal drug formulations. Rationale for development and what we can expect for the future
- (1998) Drugs , vol.56 , pp. 747-756
- Allen, T.M.¹

2
- 0021278727
- Antileishmanial activity of liposome-encapsulated meglumine antimoniate in dog
- (1984) Am. J. Vet. Res. , vol.45 , pp. 1028-1030
- Chapman W.L., Jr.¹ Hanson, C.R.² Alving, C.R.³ Hendricks, L.D.⁴

3
- 0033825073
- Leishmania infantum: Stage-specific activity of pentavalent antimony related with the assay conditions
- (2000) Exp. Parasitol. , vol.95 , pp. 209-214
- Carrió, J.¹ De Colmenares, M.² Riera, C.³ Gállego, M.⁴ Arboix, M.⁵ Portús, M.⁶

4
- 0023854488
- Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate
- (1988) Trans. R. Soc. Trop. Med. Hyg. , vol.82 , pp. 69-72
- Chulay, J.D.¹ Fleckenstein, L.² Smith, D.H.³

5
- 0022157032
- Applicability of anodic-striping voltammetry and graphite furnace atomic-absortion spectrometry to the determination of antimony in biological matrices: A comparative study
- (1985) Analyst , vol.110 , pp. 1355-1359
- Constantini, S.¹ Giordani, R.² Rizzica, M.³ Benedetti, F.⁴

6
- 0029002305
- Importance of drug carriers in the treatment of visceral leishmaniasis
- (1995) Med. Trop. , vol.55 , pp. 73-78
- Fusai, T.¹ Durand, R.² Boulard, Y.³ Paul, M.⁴ Bories, C.⁵ Rivollet, D.⁶ Houin, R.⁷ Deniau, M.⁸

7
- 0030449320
- Amphotericin B: New life for an old drug
- (1996) Trends Pharmacol. Sci. , vol.17 , pp. 445-449
- Hartsel, S.¹ Bolard, J.²

8
- 0004259632
- Statistical Consultants, Inc., Lexington, KY
- (1992) PCNONLIN User's Guide
- Metzler, C.M.¹ Weiner, D.L.²

9
- 7344232179
- Impact of liposomes as delivery systems in veterinary medicine
- (1998) Vet. Res. , vol.29 , pp. 409-430
- Sallovitz, J.M.¹ Zonco Menghini, M.I.² Lanusse, C.E.³

10
- 0002558244
- Leishmaniasis
- Green, C.E. (Ed.), Saunders, Philadelphia, PA
- (1998) Infectious Diseases of the Dog and the Cat, 2nd Edition , pp. 450-458
- Slappendel, R.J.¹ Ferrer, L.²

11
- 0005149803
- Preparation and use of liposomes in the treatment of microbial infections
- (1988) Crit. Rev. Microbiol. , vol.15 , Issue.SUPPL. 1 , pp. 1-31
- Swenson, C.E.¹ Popescu, M.C.² Ginsberg, R.S.³

12
- 0028210104
- Pharmacokinetics of N-Methylglucamine antimoniate after intravenous, intramuscular and subcutaneous administration in dog
- (1994) Res. Vet. Sci. , vol.56 , pp. 144-150
- Tassi, P.¹ Ormas, P.² Madonna, P.³ Carli, S.⁴ Belloli, C.⁵ De Natale, G.⁶ Ceci, L.⁷ Marcotrigiano, G.O.⁸

13
- 0030067708
- Disposition of antimony after administration of N-methylglucamine antimoniate to dogs
- (1996) Vet. Rec. , vol.138 , pp. 181-183
- Valladares, J.E.¹ Alberola, J.² Esteban, M.³ Arboix, M.⁴

14
- 0030875841
- Pharamacokinetics of liposome-encapsulated meglumine antimoniate after intramuscular and subcutaneous administration in dogs
- (1997) Am. J. Trop. Med. Hyg. , vol.57 , pp. 403-406
- Valladares, J.E.¹ Freixas, J.² Alberola, J.³ Franquelo, C.⁴ Cristofol, C.⁵ Arboix, M.⁶

15
- 0032519660
- Pharmacokinetics of meglumine antimoniate after administration of multiple dose in dogs experimentally infected with Leishmania infantum
- (1998) Vet. Parasitol. , vol.75 , pp. 33-40
- Valladares, J.E.¹ Riera, C.² Alberola, J.³ Gállego, M.⁴ Portús, M.⁵ Arboix, M.⁶

16
- 0004159786
- Technomic Publishing Co., Lancaster
- (1993) Pharmacokinetics for the pharmaceutical scientist , pp. 293-298
- Wagner, J.G.¹

17
- 0033545538
- Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group
- (1999) New Engl. J. Med. , vol.340 , pp. 764-771
- Walsh, T.J.¹ Finberg, R.W.² Arndt, C.³ Hiemenz, J.⁴ Schwartz, C.⁵ Bodensteiner, D.⁶ Pappas, P.⁷ Seibel, N.⁸ Greenberg, R.N.⁹ Dummer, S.¹⁰ Schuster, M.¹¹ Holcenberg, J.S.¹²

18
- 0004099766
- Technical Report Series 793, World Health Organization
- (1990) Control of the Leishmaniases

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.